New oral drug may replace insulin injection for diabetics

Credit: Karolina Grabowska / Pexels

There are some scientists in Melbourne who have made a special pill that can give people with diabetes medicine without having to use a needle.

This is really exciting news for people who need medicine that can only be given with a needle, like insulin.

The scientists used a special capsule to protect the medicine, which can break down in the part of our body that’s good for absorbing medicine.

The capsule has a special coating that is designed not to break down in the stomach’s low pH environment, but to dissolve in the small intestine, where the pH levels are higher.

This means that the medicine can pass safely through the stomach and into the small intestine, where it can be absorbed into the body.

The scientists tested this new pill with insulin, which is medicine some people with diabetes need.

Insulin is a protein drug that helps regulate blood sugar levels, but it’s challenging to deliver it orally because the drug degrades quickly in the stomach.

This is why most people with diabetes need to take insulin injections up to several times a day.

However, the scientists found that their new pill worked really well for the slow-acting form of insulin.

This is great news because slow-acting insulin acts over a much longer timeframe, up to a day or so, to keep the insulin in the body steady.

The capsule achieved good absorption results for the slow-acting insulin, about 50% better than injection delivery for the same quantity of insulin.

This means that people with diabetes may not have to use needles as often in the future!

Unfortunately, the new pill didn’t work as well for the fast-acting form of insulin, which is needed when controlling blood sugar after a meal.

The insulin took too long to take effect, which would make it less practical for most people with diabetes.

The scientists think that this new pill can also be used for other types of medicine that are hard to take in a pill form, which is really exciting news.

Other protein drugs such as monoclonal antibodies have been developed to treat inflammatory conditions, cancer, and other diseases, with a projected market value of about $400 billion by 2030.

The team explained that the new pill works by packaging the insulin inside a fatty nanomaterial within the capsule that helps camouflage the insulin so that it can cross the intestinal walls.

The nanomaterial also helps keep the insulin active and safe during delivery in the body.

This is important because, for many pre-clinical trials, the oral formulations contain much higher levels of insulin to achieve the same response as the injection delivery.

This is not a very cost-effective way to deliver protein drugs which tend to be expensive.

The new technology could also be used to deliver other protein drugs orally, including a new type of oral antibiotic developed by the RMIT team that can avoid resistance to dangerous superbugs.

The research team has filed an international patent application for their technology, and they are doing more pre-clinical testing so they can move to clinical trials as soon as possible.

If you care about diabetes, please read studies about a major breakthrough in diabetes treatment, and this drug for inflammation may increase your diabetes risk within days.

For more information about weight loss, please see recent studies that vegan diet rich in legumes may help you lose weight, and results showing this diabetes drug can help people lose never-before-seen amounts of weight.

The study was conducted by Jamie B. Strachan et al and published in Biomaterials Advances.

Copyright © 2023 Knowridge Science Report. All rights reserved.